How to Take Cabergoline
Cabergoline should be taken at an initial dose of 0.25 mg twice weekly, with gradual increases of 0.25 mg twice weekly up to a maximum of 1 mg twice weekly based on prolactin response, with dose adjustments occurring no more frequently than every 4 weeks. 1
Dosing Protocol
- Starting dose: 0.25 mg twice weekly
- Dose adjustments: Increase by 0.25 mg twice weekly as needed
- Maximum standard dose: 1 mg twice weekly
- Adjustment frequency: Not more often than every 4 weeks
- Duration: Continue until normal prolactin levels are maintained for 6 months, then consider discontinuation with monitoring 1
Administration Tips
- Take with or without food
- Taking doses at night or in small increments can help reduce side effects like gastrointestinal intolerance and postural hypotension 2
- For patients experiencing side effects, small nocturnal dose increments are recommended rather than switching to less effective dopamine agonists 2
Monitoring and Follow-up
- Before starting: Cardiovascular evaluation should be performed; echocardiography should be considered to assess for valvular disease 1
- During treatment:
Special Considerations
- Resistance to standard doses: For patients not responding to standard doses, graduated dose increments up to 3.5 mg per week may be considered 2
- Exceptional cases: Doses up to 7 mg per week may be used in rare situations where lower doses are ineffective 2
- Treatment discontinuation: After normal prolactin levels have been maintained for 6 months, cabergoline may be discontinued with periodic monitoring to determine if/when treatment should be restarted 1
Potential Side Effects to Monitor
- Gastrointestinal symptoms (nausea, vomiting)
- Postural hypotension
- Psychological effects (mood changes, depression, impulse control disorders) 2
- Cerebrospinal fluid leak (rare complication in patients with prolactinomas that have invaded sphenoid bone) 2
Important Precautions
- Cabergoline has a long half-life (63-109 hours), allowing for twice-weekly dosing 3
- Higher doses are typically needed for macroprolactinomas compared to microprolactinomas or idiopathic hyperprolactinemia 4
- Cabergoline is generally better tolerated than other dopamine agonists like bromocriptine 5
- Patients with resistance or intolerance to high-dose cabergoline may require adjuvant therapy with surgery or radiotherapy 2